Ionis shares tumble19% after Roche halts Phase 3 study for rare-disease drug

Retrieved on: 2021-03-23 11:59:38

Tags for this article:

Click the tags to see associated articles and topics

Ionis shares tumble19% after Roche halts Phase 3 study for rare-disease drug. View article details on hiswai:

Excerpt

Roche licensed the investigational therapy, tominersen, from Ionis in December 2017. However, an independent data monitoring committee first made ...

Article found on: www.marketwatch.com